The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology
Open accessAbstract
Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmidt, E., & Zillikens, D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61140-4 · Cited by 1,015
Self-citationRecommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Grossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid
Joly, P., Roujeau, J.-C., Benichou, J., Picard, C., Dreno, B., Delaporte, E., Vaillant, L., D'Incan, M., Plantin, P., Bedane, C., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011592 · Cited by 626
Self-citationMolecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
Labib, R. S., Anhalt, G. J., Patel, H. P., Mutasim, D. F., & Diaz, L. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.4.1231 · Cited by 515
Nicotinamide and Tetracycline Therapy of Bullous Pemphigoid
Fivenson, D. P. (1994) · Archives of Dermatology · doi:10.1001/archderm.130.6.753 · Cited by 250
Joly, P., Roujeau, J.-C., Benichou, J., Delaporte, E., D'Incan, M., Dreno, B., Bedane, C., Sparsa, A., Gorin, I., Picard, C., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.412 · Cited by 241
Self-citationBritish Association of Dermatologists’ guidelines for the management of bullous pemphigoid 2012
Venning, V. A., Taghipour, K., Mohd Mustapa, M. F., Highet, A. S., Kirtschig, G., Hughes, J. R., McLelland, J., McDonagh, A. J., Punjabi, S., Buckley, D. A., et al. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12072 · Cited by 227
Gammon, W. R., Kowalewski, C., Chorzelski, T. P., Kumar, V., Briggaman, R. A., & Beutner, E. H. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70094-x · Cited by 204
Self-citationMulticenter prospective study of the humoral autoimmune response in bullous pemphigoid
Di Zenzo, G., Thoma-Uszynski, S., Fontao, L., Calabresi, V., Hofmann, S. C., Hellmark, T., Sebbag, N., Pedicelli, C., Sera, F., Lacour, J.-P., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.04.012 · Cited by 192
Self-citationRituximab in autoimmune bullous diseases: mixed responses and adverse effects
Schmidt, E., Seitz, C. S., Benoit, S., Bröcker, E. B., & Goebeler, M. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07646.x · Cited by 189
Interventions for bullous pemphigoid
Kirtschig, G., Middleton, P., Bennett, C., Murrell, D. F., Wojnarowska, F., & Khumalo, N. P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002292.pub3 · Cited by 188
Drugs associated with bullous pemphigoid. A case-control study
Bastuji‐Garin, S. (1996) · Archives of Dermatology · doi:10.1001/archderm.132.3.272 · Cited by 158
Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
Fairley, J. A., Baum, C. L., Brandt, D. S., & Messingham, K. N. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.035 · Cited by 154
Fichel, F., Barbe, C., Joly, P., Bédane, C., Vabres, P., Truchetet, F., Aubin, F., Michel, C., Jegou, J., Grange, F., et al. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5757 · Cited by 86
Self-citationImmunoadsorption in Dermatology
Meyersburg, D., Schmidt, E., Kasperkiewicz, M., & Zillikens, D. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2012.01075.x · Cited by 71
Self-citation
Cited by
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment
Bernard, P., & Antonicelli, F. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0264-2 · Cited by 257
Unmet medical needs in chronic, non-communicable inflammatory skin diseases
Ujiie, H., Rosmarin, D., Schön, M. P., Ständer, S., Boch, K., Metz, M., Maurer, M., Thaci, D., Schmidt, E., Cole, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.875492 · Cited by 158
Metadata
- Authors
- Feliciani, C., Joly, P., Jonkman, M. F., Zambruno, G., Zillikens, D., Ioannides, D., Kowalewski, C., Jedlickova, H., Kárpáti, S., Marinovic, B., Mimouni, D., Uzun, S., Yayli, S., Hertl, M., & Borradori, L.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04
- Volume
- 172
- Issue
- 4
- Pages
- 867-877
- ISSN
- 0007-0963 (ISSN-L)
- OpenAlex
- W2113309969
- Cited by
- 314
- References
- 16
- FWCI
- 19.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.